Istanbul Faculty of Medicine, Department of Pediatrics, Istanbul University, Istanbul, Turkey.
Istanbul Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology, Istanbul University, Capa, 34093, Istanbul, Turkey.
Eur J Pediatr. 2018 Nov;177(11):1593-1601. doi: 10.1007/s00431-018-3211-1. Epub 2018 Jul 28.
The aim of this study was to analyze the relationship between premature adrenarche (PA) and metabolic syndrome (MeS) parameters at presentation and during puberty. This study comprised 47 girls with PA. Age- and puberty-matched 22 healthy girls without PA were the control group. Patients were evaluated at admission (first evaluation) and later in puberty (second evaluation). Anthropometric measurements, lipid levels, and hormonal parameters were studied and oral glucose tolerance test was performed. Indices for insulin resistance (IR) were calculated. The study group was divided in subgroups according to body mass index (BMI) and compared with the control group. The age of the PA group at first evaluation was 8.0 ± 1.1 years; mean height SDS and BMI SDS were 0.4 ± 1.2 and 0.6 ± 0.9, respectively. Age of PA group at the second evaluation was 12.9 ± 2.4 years. Frequency of obesity and overweight was 14.9 and 23.4%. Dyslipidemia ratio was 28.3%. PA group had significantly higher BMI than controls. Mean insulin concentration was higher and mean glucose and FGIR were lower in PA group and also dyslipidemia ratio was 5.3 times higher in PA than controls (p = 0.040). In PA group, overweight/obese subjects had still higher BMI at second evaluation and also higher fasting glucose, insulin, HOMA-IR. However, PA children with exaggerated DHEAS concentrations compared to those without had similar BMI SDS, insulin sensitivity, and secretion indices and lipid profile at second evaluation. BMI SDS at first evaluation was positively correlated with HOMA-IR at puberty; however, there is no correlation between DHEAS at first evaluation and HOMA-IR at puberty.Conclusion: BMI at adrenarche is more important than prepubertal adrogen concentrations such as DHEAS, while predicting the IR in puberty. Long-term follow-up of children supports the observation that PA per se may be related to IR; however, the risk increases with obesity. What is Known: • Premature adrenarche (PA) is receiving more attention as evidence emerges for a relation between early androgen excess and metabolic syndrome. • The onset of the adrenal androgen production before 8 years in girls defined as PA. Pubarche, axillary hair, apocrine body odor, acne are typical phenotypic features of PA. What is New: • Body mass index at adrenarche is an important risk factor for development of insulin resistance in pubertal ages. • Degree of dehydroepiandrosterone sulfate elevation was not shown as a risk factor for insulin resistance.
本研究旨在分析青春期前肾上腺功能亢进症(PA)与代谢综合征(MeS)参数在初诊时和青春期的关系。本研究纳入了 47 例 PA 女孩。年龄和青春期匹配的 22 例无 PA 的健康女孩作为对照组。患者在入院时(首次评估)和青春期后(第二次评估)进行评估。研究了人体测量学指标、血脂水平和激素参数,并进行了口服葡萄糖耐量试验。计算了胰岛素抵抗(IR)指数。根据体重指数(BMI)将研究组分为亚组,并与对照组进行比较。PA 组首次评估时的年龄为 8.0±1.1 岁;平均身高 SDS 和 BMI SDS 分别为 0.4±1.2 和 0.6±0.9。PA 组第二次评估时的年龄为 12.9±2.4 岁。肥胖和超重的发生率分别为 14.9%和 23.4%。血脂异常率为 28.3%。PA 组的 BMI 明显高于对照组。PA 组的平均胰岛素浓度较高,空腹血糖和 FGIR 较低,PA 组的血脂异常率也比对照组高 5.3 倍(p=0.040)。在 PA 组中,超重/肥胖受试者在第二次评估时的 BMI 仍较高,空腹血糖、胰岛素、HOMA-IR 也较高。然而,与 DHEAS 浓度无明显升高的 PA 患儿相比,DHEAS 浓度明显升高的 PA 患儿在第二次评估时的 BMI SDS、胰岛素敏感性和分泌指数以及血脂谱无明显差异。青春期前评估时的 BMI SDS 与青春期时的 HOMA-IR 呈正相关;然而,青春期前评估时的 DHEAS 与青春期时的 HOMA-IR 无相关性。结论:青春期前的 BMI 比青春期前的雄激素浓度(如 DHEAS)更能预测青春期的 IR。对儿童的长期随访支持这样一种观点,即 PA 本身可能与 IR 有关;然而,肥胖会增加这种风险。已知:• 越来越多的证据表明,早期雄激素过多与代谢综合征有关,因此青春期前肾上腺功能亢进症(PA)受到更多关注。• 女孩 8 岁前出现肾上腺雄激素产生被定义为 PA。性早熟、腋毛、顶泌体体味、痤疮是 PA 的典型表型特征。新内容:• 青春期前的 BMI 是青春期发生胰岛素抵抗的重要危险因素。• DHEAS 升高的程度并未显示为胰岛素抵抗的危险因素。